GF
CNST

Gabelli Funds’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Gabelli Funds’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-380,583
Closed -$12.9M – 1504
2021
Q2 		$12.9M Buy
+380,583
New +$9.7M 0.08% 310

Gabelli Funds's CNST Position: Q3 2021 in Review

Gabelli Funds sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 380,583 shares — an estimated $12.9M sold.

Gabelli Funds first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $12.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Gabelli Funds reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Gabelli Funds sold 380,583 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $12.9M.
  • Gabelli Funds first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Gabelli Funds's Constellation Pharmaceuticals, Inc. position peaked at $12.9M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Gabelli Funds's 13F filing for Q3 2021, filed 12 Nov 2021.